RAC 0.59% $1.71 race oncology ltd

Ann: Race Receives Governance Approval for AML EMD & MDS Trial, page-25

  1. 2,632 Posts.
    lightbulb Created with Sketch. 2382
    Great news; expected outcome; inside the expected timeframe; all systems go.

    I hope that this trial helps more people realise what this arm of Race's strategy means. It is a trial to see if there is a treatment for a currently un-curable disease and it is a trial to see if the use of Zantrene stops a huge proportion of cancers that are resistant to immunotherapy treatments.

    It is very exciting to be the world first FTO cancer therapy trial in the clinic. I hope people see this fact and that the trial goes well for all concerned.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.71
Change
0.010(0.59%)
Mkt cap ! $291.1M
Open High Low Value Volume
$1.74 $1.75 $1.70 $226.9K 131.5K

Buyers (Bids)

No. Vol. Price($)
1 9599 $1.71
 

Sellers (Offers)

Price($) Vol. No.
$1.74 4886 1
View Market Depth
Last trade - 16.10pm 25/06/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.